Paula Britto

1.2k total citations
25 papers, 828 citations indexed

About

Paula Britto is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Paula Britto has authored 25 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 20 papers in Virology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Paula Britto's work include HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (20 papers) and HIV/AIDS Research and Interventions (18 papers). Paula Britto is often cited by papers focused on HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (20 papers) and HIV/AIDS Research and Interventions (18 papers). Paula Britto collaborates with scholars based in United States, Thailand and Cameroon. Paula Britto's co-authors include John L. Sullivan, Lynne Mofenson, Katherine Luzuriaga, Margaret McManus, Bobbie Graham, George McSherry, David E. Shapiro, Rhoda Sperling, Robert W. Coombs and Lisa M. Frenkel and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Paula Britto

25 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paula Britto United States	15	719	526	199	170	75	25	828
Henry Sunpath United States	19	914 1.3×	630 1.2×	245 1.2×	114 0.7×	86 1.1×	47	1.0k
Valérie Journot France	16	777 1.1×	491 0.9×	227 1.1×	301 1.8×	65 0.9×	29	990
Rawiwan Hansudewechakul Thailand	17	685 1.0×	346 0.7×	229 1.2×	267 1.6×	113 1.5×	64	874
Paola Germano Italy	14	522 0.7×	263 0.5×	198 1.0×	150 0.9×	107 1.4×	25	635
N. Kumarasamy India	16	643 0.9×	356 0.7×	301 1.5×	185 1.1×	54 0.7×	21	772
Béatrice Barret France	6	589 0.8×	293 0.6×	258 1.3×	337 2.0×	58 0.8×	6	821
Monica Airoldi Italy	11	525 0.7×	349 0.7×	218 1.1×	167 1.0×	25 0.3×	27	728
Afaaf Liberty South Africa	11	418 0.6×	252 0.5×	150 0.8×	129 0.8×	89 1.2×	27	532
Roland Landman France	16	815 1.1×	541 1.0×	242 1.2×	152 0.9×	20 0.3×	63	917
Marjorie Dehlinger United States	11	516 0.7×	336 0.6×	163 0.8×	112 0.7×	68 0.9×	12	639

Countries citing papers authored by Paula Britto

Since Specialization

Citations

This map shows the geographic impact of Paula Britto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Britto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Britto more than expected).

Fields of papers citing papers by Paula Britto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Britto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Britto. The network helps show where Paula Britto may publish in the future.

Co-authorship network of co-authors of Paula Britto

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Britto. A scholar is included among the top collaborators of Paula Britto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Britto. Paula Britto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mathad, Jyoti S., Rada Savic, Paula Britto, et al.. (2021). Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women. Clinical Infectious Diseases. 74(9). 1604–1613. 22 indexed citations

Rodrigues, Vandílson Pinheiro, et al.. (2020). Effects of water‐ and land‐based exercises on quality of life and physical aspects in women with fibromyalgia: A randomized clinical trial. Musculoskeletal Care. 18(4). 459–466. 13 indexed citations

Britto, Paula, Sean S. Brummel, Risa M. Hoffman, et al.. (2019). Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men. AIDS. 33(14). 2149–2156. 12 indexed citations

Currier, Judith S., Paula Britto, Risa M. Hoffman, et al.. (2017). Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3. PLoS ONE. 12(5). e0176009–e0176009. 15 indexed citations

Foca, Marc, Ram Yogev, Andrew Wiznia, et al.. (2016). Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young Adults. The Pediatric Infectious Disease Journal. 35(9). e271–e274. 6 indexed citations

Cressey, Tim R., Rohan Hazra, Andrew Wiznia, et al.. (2016). Pharmacokinetics of Unboosted Atazanavir in Treatment-experienced HIV-infected Children, Adolescents and Young Adults. The Pediatric Infectious Disease Journal. 35(12). 1333–1335. 2 indexed citations

Larson, Kajal, Tim R. Cressey, Ram Yogev, et al.. (2015). Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults. Journal of the Pediatric Infectious Diseases Society. 5(2). 131–137. 8 indexed citations

Gaur, Aditya H., Marvin Belzer, Paula Britto, et al.. (2010). Directly Observed Therapy (DOT) for Nonadherent HIV-Infected Youth: Lessons Learned, Challenges Ahead. AIDS Research and Human Retroviruses. 26(9). 947–953. 23 indexed citations

King, Jennifer R., Edward P. Acosta, Ram Yogev, et al.. (2009). STEADY-STATE PHARMACOKINETICS OF LOPINAVIR/RITONAVIR IN COMBINATION WITH EFAVIRENZ IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PEDIATRIC PATIENTS. The Pediatric Infectious Disease Journal. 28(2). 159–161. 6 indexed citations

10.

Weinberg, Adriana, Ruth Dickover, Paula Britto, et al.. (2008). Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy. AIDS. 22(17). 2267–2277. 24 indexed citations

11.

Kovács, Andrea, Mary Kathryn Cowles, Paula Britto, et al.. (2005). Pharmacokinetics of Didanosine and Drug Resistance Mutations in Infants Exposed to Zidovudine During Gestation or Postnatally and Treated With Didanosine or Zidovudine in the First Three Months of Life. The Pediatric Infectious Disease Journal. 24(6). 503–509. 3 indexed citations

12.

Chadwick, Ellen G., John H. Rodman, Paula Britto, et al.. (2005). Ritonavir-Based Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Infants Younger Than 24 Months of Age. The Pediatric Infectious Disease Journal. 24(9). 793–800. 31 indexed citations

13.

Luzuriaga, Katherine, Margaret McManus, Lynne Mofenson, et al.. (2004). A Trial of Three Antiretroviral Regimens in HIV-1–Infected Children. New England Journal of Medicine. 350(24). 2471–2480. 106 indexed citations

14.

Cunningham, Coleen K., Marie‐Laure Chaix, Claire Rekacewicz, et al.. (2002). Development of Resistance Mutations in Women Receiving Standard Antiretroviral Therapy Who Received Intrapartum Nevirapine to Prevent Perinatal Human Immunodeficiency Virus Type 1 Transmission: A Substudy of Pediatric AIDS Clinical Trials Group Protocol 316. The Journal of Infectious Diseases. 186(2). 181–188. 99 indexed citations

15.

Scott, Zachary, Ellen G. Chadwick, Laura Gibson, et al.. (2001). Infrequent Detection of HIV-1-Specific, But Not Cytomegalovirus-Specific, CD8+ T Cell Responses in Young HIV-1-Infected Infants. The Journal of Immunology. 167(12). 7134–7140. 57 indexed citations

16.

McSherry, George, David E. Shapiro, Robert W. Coombs, et al.. (1999). The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076). The Journal of Pediatrics. 134(6). 717–724. 17 indexed citations

17.

Luzuriaga, Katherine, Hulin Wu, Margaret McManus, et al.. (1999). Dynamics of Human Immunodeficiency Virus Type 1 Replication in Vertically Infected Infants. Journal of Virology. 73(1). 362–367. 63 indexed citations

18.

Eastman, Peter, David E. Shapiro, Robert W. Coombs, et al.. (1998). Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Pediatric AIDS Clinical Trials Group Protocol 076. The Journal of Infectious Diseases. 177(3). 557–564. 107 indexed citations

19.

Sperling, Rhoda, David E. Shapiro, George McSherry, et al.. (1998). Safety of the maternal–infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS. 12(14). 1805–1813. 123 indexed citations

20.

Bakshi, Saroj, Paula Britto, Edmund V. Capparelli, et al.. (1997). Evaluation of Pharmacokinetics, Safety, Tolerance, and Activity of Combination of Zalcitabine and Zidovudine in Stable, Zidovudine‐Treated Pediatric Patients with Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 175(5). 1039–1050. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact